Cancer Treatment Research in Connecticut
Cancer Treatment Research (93.395) awarded $77.2 million to recipients in Connecticut in 56 grants from fiscal 2021 to 2025, 1.4% of the program's national total. Yale Univ received the most, $52.9 million.
- Awarded in Connecticut$77.2 million
- Awards56
- Share of the program1.4%
- Rank among states20th of 50
- National total$5.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 22 | $12.5 million |
| FY 2022 | 26 | $12.8 million |
| FY 2023 | 36 | $21.4 million |
| FY 2024 | 29 | $14.1 million |
| FY 2025 | 26 | $16.5 million |
Recipients in Connecticut
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Yale Univ | Colleges and universities | 33 | $52.9 million |
| University of Connecticut Health Center | Colleges and universities | 10 | $8.8 million |
| Tezcat Biosciences, Inc. | Small businesses | 3 | $3.5 million |
| University of Connecticut Health Center | Colleges and universities | 3 | $2.8 million |
| Modifi Biosciences Inc | Small businesses | 1 | $2.4 million |
| Thetis Pharmaceuticals LLC | Small businesses | 1 | $2.1 million |
| Nami Therapeutics Corp | Small businesses | 1 | $2.0 million |
| Isoplexis Corporation | Small businesses | 1 | $1.2 million |
| Cybrexa, Inc. | Small businesses | 1 | $820,611 |
| Cellinfinity Bio Inc | Small businesses | 2 | $800,000 |
Open opportunities under this program
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
See all 45 on the program page
Questions people ask
How much Cancer Treatment Research money goes to Connecticut?
$77.2 million from fiscal 2021 to 2025, across 56 awards. Connecticut ranks 20th of 50 states and territories for this program.
Who receives Cancer Treatment Research money in Connecticut?
The largest recipient is Yale Univ, with $52.9 million in 33 awards. Next are University of Connecticut Health Center and Tezcat Biosciences, Inc..
Can organizations in Connecticut apply now?
Yes, 45 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Treatment Research in other states
Other large programs in Connecticut
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Temporary Assistance for Needy Families
- National School Lunch Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- USAID Foreign Assistance for Programs Overseas
- Special Education Grants to States
- Title I Grants to Local Educational Agencies